AMRZ Amrize Ltd
$40.23▲ +2.52%
Materials
Other
After hours
$40.23▲ +0.00%
Oct 27, 4:06 PM ET
Volume 5.35M
Avg Volume (10D) 3.70M
Key Metrics & Fundamentals
Market Cap
$22.00B
P/E Ratio
18.4
Div Yield
0.00%
52W Range
35.79 - 65.94
% vs 50 MA
0.70%
% vs 200 MA
-20.78%
RSI-14
62.7
MACD Histogram
+0.5700
Beta (1Y vs SPY)
1.31
Free Cash Flow
$173.00M
Gross Rev
$3.49B
Gross Profit
$993.00M
EBITDA
$963.00M
COGS
$2.50B
Operating Exp
$283.00M
Operating Income
$710.00M
EBIT
$710.00M
Pretax Income
$621.00M
Net Income
$478.00M
EPS (Diluted)
0.86
Price & Volume History
Loading chart…
Recent News
Do Options Traders Know Something About Amrize Stock We Don't?
Zacks · Oct 27, 2026 7:54 AM ET
Earnings Preview: Amrize Ltd (AMRZ) Q3 Earnings Expected to Decline
Zacks · Oct 21, 2026 9:00 AM ET
Amrize (AMRZ) Benefits from Regional Scale, Tight Supply Dynamics, and Pricing Power
Insider Monkey · Oct 15, 2026 11:45 AM ET
Amrize Announces Date for Third Quarter 2026 Financial Results
Business Wire · Oct 14, 2026 9:00 AM ET
RBC Cuts Price Target on Amrize to $32 From $48, Keeps Underperform Rating
MT Newswires · Oct 9, 2026 6:45 AM ET
Asurion Names Baris Oran Chief Financial Officer
PR Newswire · Oct 5, 2026 12:00 PM ET
Truist Securities Adjusts Amrize Price Target to $35 From $48, Maintains Hold Rating
MT Newswires · Oct 5, 2026 8:28 AM ET
Bear of the Day: Amrize (AMRZ)
Zacks · Oct 1, 2026 3:00 AM ET
New Strong Sell Stocks for September 29th
Zacks · Sep 29, 2026 4:41 AM ET
Deutsche Bank Cuts Price Target on Amrize to $56 From $64, Keeps Buy Rating
MT Newswires · Sep 23, 2026 7:25 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See AMRZ's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.